Beyond the next superfood: Building the capability to keep up with nutrition

The food and beverage industry has always been steered by health trends. Low fat defined the 1980s. Low carb took over by the late 1990s, propelled by the Atkins revival, arriving almost as a direct rebuttal to everything low fat had asked people to eat instead. Portion control and calorie counting dominated the mid-2000s. Gluten free and a wave of superfoods carried the 2010s, and keto closed that decade out by turning fat, of all things, back into a virtue. 

Each wave gave brands a runway of several years to reformulate, relaunch and reposition before the arrival of the next. That runway has now disappeared.  

Low fat to low carb took roughly fifteen years to completely shift into while the calorie awareness era took less than ten. Keto went from niche to appearing on mainstream snack packages within a couple of years and by the early 2020’s, the protein and gut health stopped waiting their turn and simply started to climb together. With protein water and gut-friendly sodas stocking the shelves of grocery stores, the trends have turned to competing for shelf space rather than replacing one another in sequence. 

Gut health claims in new product launches grew 61 percent in a single year and personalized nutrition, once a distinct system built around DNA testing and supplement subscriptions is expected to double in market size by 2030. As AI recommendations and biomarker tracking continue to grow in popularity amongst the health community, this will only become normalcy. Alongside, weight loss medications have seemingly rewritten the contents of the average grocery basket in under two years, with an estimated one in five US households having a GLP-1 user. Unlike every other wave, GLP-1 isn’t redirecting demand towards a new nutrient, it’s lowering it entirely. This is a brand-new kind of disruption to the market that fats, carbs, gluten, keto, or protein never presented.  

This creates a unique problem that most retail and CPG teams have traditionally organized to solve. Reformulation has a clear answer: change the recipe, update the packaging, relaunch. Rapidly shifting demand is harder to solve. When the underlying driver of demand is shaping at a faster pace than the innovation cycle, the fix isn’t a better product. The answer is a more adaptable system for producing one.  

The real question facing food and beverage brands isn’t which ingredients or trend to bet on next, but rather if the organization can reset their assumptions of what consumers are seeking next as fast as consumers are resetting theirs.  

The gap between those two speeds is stark once you put the numbers side by side. The mismatch becomes clear when you put the timelines side by side. Most large food and beverage companies still run new product development through some form of stage-gate process. A line extension can take three to six months; a genuinely new product using existing equipment, six to 12 months; and a product requiring new ingredients or equipment, 18 to 36 months. Shelf-life testing can add further time, often reflecting the product’s intended shelf life. 

Consumer trends, meanwhile, can emerge, accelerate and begin to fade within those same development windows. That means a brand embarking on an 18-to-36-month innovation cycle today is making a significant bet: that the consumer need or behavior it is responding to will still be relevant by the time the product reaches the shelf. As trend cycles accelerate, that bet becomes increasingly difficult to make with confidence. So, what are we currently witnessing?  What does it demand of brands? 

Insight one: Shoppers are buying outcomes not ingredients

Almost nobody goes to the store in search of fiber, a specific probiotic strain, or a gram count of protein. What consumers are after are the benefits of these nutrients: more energy, deeper sleep, better digestion, muscle maintenance, sharper focus, the list goes on. The ingredient is simply the vehicle to specific outcomes, but the credible routes keep changing. 

This is visible in the uprising of claim language and benefit descriptions presented on packages. Gut health products are marketed alongside immunity and mood benefits and magnesium for better sleep and calmness. Consumers are thinking of their health in connected buzzwords. A brand that ties its innovation pipeline to a specific nutrient is betting that the nutrient itself stays fashionable. A brand that ties its pipeline to the underlying outcome is betting on something much more durable: that people will continue to desire a strong immune system and better sleep, regardless of which ingredient delivers the ‘solution’ currently.  

Insight two: Categories that sit apart are converging

The traditional structure of the aisle assumed each product solved a single shopper’s need. The most successful brands are now layering solutions instead. When shoppers scan the protein bar section, the winners aren’t the ones with the most protein, they’re the ones offering something extra on top of it. Electrolyte packets now come with creatine added in. What lands in the basket increasingly does more than one job. 

This convergence alters what innovation actually means. It’s no longer enough to own one benefit clearly. Brands need a credible answer for why their product belongs in more than one part of a consumer’s health goals, and that answer must hold up without an overcrowded claim list that none of it feels believable. 

Insight three: Personalization is turning from a premium feature into the baseline

Personalized nutrition was historically a niche segment sought out deliberately by those willing to pay for the premium experience of genetic tests or subscription meal plans. Now with the uprising of AI and technological advances in wearables and biomarker monitoring, it’s rapidly becoming the standard infrastructure. 

Brands must guard against the credibility gap this creates. The reliability problem is already visible in microbiome testing: a recent study sent identical samples to seven testing companies and received results with major discrepancies. Poppi ran into a version of the same problem from the branding side, facing a class action lawsuit challenging whether its prebiotic fiber content actually delivered the gut health benefit the brand had marketed. Neither case suggests fraud so much as a category moving faster than its own evidence. But the effect is the same either way: personalization and functional claims can win adoption well before the science behind them is rigorous enough to survive scrutiny. Consumers are increasingly capable of noticing the gap once it’s exposed, which is exactly why trust must be built deliberately, not assumed as a byproduct of adoption. 

Insight four: Winning organizations don’t predict trends, they respond faster

With these shifts compounding rather than taking turns, the brands pulling ahead aren’t the ones with the best forecast of what comes after protein or gut health or GLP-1. They’re the ones with a shorter distance between noticing a shift and acting on it. A five-year innovation roadmap is not a liability because the destination is wrong. It’s a liability because it assumes the destination will hold still long enough to get there. 

For brands and retailers to stay ahead in this environment, it’s important to make the following moves: 

1. Organize the portfolio around outcomes, not ingredients

Most innovation pipelines are still structured around a hero ingredient: 25g of protein, high fiber, a specific probiotic strain. That structure works until the ingredient falls out of favor, at which point the whole pipeline needs rebuilding. A portfolio structured around durable outcomes, energy, immunity, satiety, healthy aging, can absorb a new ingredient without redesigning because the ingredient was never the focal point. Brands should audit their current pipeline and ask which products are anchored to a specific nutrient that could lose relevance versus which are anchored to a consumer goal that won’t. 

2. Build for overlap, but earn the right to claim it

As categories converge, the winning move isn’t to add more claims to a label, it’s to pick the two or three benefits that genuinely belong together and substantiate them credibly. This means investing in the evidence behind combined claims, not just the marketing copy. Though brands must find the right balance between overloading a package with benefits and having enough to differentiate themselves from competitors. In a market where consumers are already primed to question personalization claims, credibility earned early will matter more than breadth claimed early. 

3. Shrink the distance between trend signals and shelves

The core operational task isn’t picking the right trend; it’s cutting the time between spotting a shift in consumer behavior and getting a tested response into market. That means treating consumer signals as continuous input rather than an annual planning exercise. The real advantage lies in building enough flexibility into manufacturing, packaging and commercial decisions that a new direction can be tested in weeks rather than renegotiated over quarters. Governance built for reliability and scale still matters, but it needs to coexist with faster, smaller bets rather than replace them. 

Nutrition trends are not going to slow down or take turns for anyone’s convenience.

Protein, gut health, personalization and GLP-1 driven demand are only the shifts we can see clearly right now, and there will be others behind them moving just as fast. 

Brands that treat each new trend as a one-off product decision will keep finding themselves a step behind. Brands that build the underlying capability, outcome-based innovation, credible overlap and a shorter loop between insight and execution, put themselves in a different position entirely. They stop chasing the next shift and start being the brand consumers already trust to have kept up with the last three. 

That trust is not the starting point. It’s the payoff for having built the capability to earn it.